Ecklonia cava extracts for alleviating or preventing asthmatic reactions
US8722098B2 · kind B2 · utility
0Cited by
1References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 6, 2007 |
| Grant date | May 13, 2014 |
| Priority date | — |
| Expiry date | Jul 6, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0019
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of alleviating or preventing inflammation in an animal is provided. In concrete, the method comprises the step of administering to an animal a composition including an Ecklonia cava extract in an amount effective to suppress SOCS-3 expression in the animal to thereby alleviate or prevent inflammation in the animal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.